A general ANN-based multitasking model for the discovery of potent and safer antibacterial agents.

Bacteria have been one of the world's most dangerous and deadliest pathogens for mankind, nowadays giving rise to significant public health concerns. Given the prevalence of these microbial pathogens and their increasing resistance to existing antibiotics, there is a pressing need for new antibacterial drugs. However, development of a successful drug is a complex, costly, and time-consuming process. Quantitative Structure-Activity Relationships (QSAR)-based approaches are valuable tools for shortening the time of lead compound identification but also for focusing and limiting time-costly synthetic activities and in vitro/vivo evaluations. QSAR-based approaches, supported by powerful statistical techniques such as artificial neural networks (ANNs), have evolved to the point of integrating dissimilar types of chemical and biological data. This chapter reports an overview of the current research and potential applications of QSAR modeling tools toward the rational design of more efficient antibacterial agents. Particular emphasis is given to the setup of multitasking models along with ANNs aimed at jointly predicting different antibacterial activities and safety profiles of drugs/chemicals under diverse experimental conditions.

[1]  B. Song,et al.  Synthesis, Antibacterial Activities, and 3D‐QSAR of Sulfone Derivatives Containing 1, 3, 4‐Oxadiazole Moiety , 2013, Chemical biology & drug design.

[2]  Francisco Torrens,et al.  Atom, atom-type, and total nonstochastic and stochastic quadratic fingerprints: a promising approach for modeling of antibacterial activity. , 2005, Bioorganic & medicinal chemistry.

[3]  Ernesto Estrada,et al.  Physicochemical Interpretation of Molecular Connectivity Indices , 2002 .

[4]  Philippe Glaziou,et al.  Global tuberculosis control: lessons learnt and future prospects , 2012, Nature Reviews Microbiology.

[5]  Frank Alber,et al.  Quantum medicinal chemistry , 2003 .

[6]  Kun Huang,et al.  Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors , 2012, International journal of molecular sciences.

[7]  Lourdes Santana,et al.  Markovian chemicals “in silico” design (MARCH-INSIDE), a promising approach for computer-aided molecular design III: 2.5D indices for the discovery of antibacterials , 2005 .

[8]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[9]  William W. Hope,et al.  Cefadroxil, cephaloridine, cephacetrile, cephapirin, cephradine, and other rarely used first-generation cephalosporins , 2017 .

[10]  Kunal Roy,et al.  QSTR with Extended Topochemical Atom Indices. 10. Modeling of Toxicity of Organic Chemicals to Humans Using Different Chemometric Tools , 2008, Chemical biology & drug design.

[11]  R. Borchardt Optimizing the "drug-like" properties of leads in drug discovery , 2006 .

[12]  M. Natália D. S. Cordeiro,et al.  Chemoinformatics in Drug Design. Artificial Neural Networks for Simultaneous Prediction of Anti-enterococci Activities and Toxicological Profiles , 2013, IJCCI.

[13]  Ernesto Estrada,et al.  A novel approach for the virtual screening and rational design of anticancer compounds. , 2000, Journal of medicinal chemistry.

[14]  Feng Luan,et al.  TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. , 2013, Bioorganic & medicinal chemistry.

[15]  Blaise Hanczar,et al.  Small-sample precision of ROC-related estimates , 2010, Bioinform..

[16]  Stephen R. Garner,et al.  WEKA: The Waikato Environment for Knowledge Analysis , 1996 .

[17]  J. Krysiński,et al.  Artificial neural networks for prediction of antibacterial activity in series of imidazole derivatives. , 2004, Combinatorial chemistry & high throughput screening.

[18]  Humberto González-Díaz,et al.  Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. , 2010, Bioorganic & medicinal chemistry.

[19]  Enrique Molina Pérez,et al.  Design of novel antituberculosis compounds using graph-theoretical and substructural approaches , 2009, Molecular Diversity.

[20]  Ernesto Estrada,et al.  Generalized Topological Indices. Modeling Gas-Phase Rate Coefficients of Atmospheric Relevance , 2007, J. Chem. Inf. Model..

[21]  Ernesto Estrada,et al.  Spectral Moments of the Edge Adjacency Matrix in Molecular Graphs. 3. Molecules Containing Cycles , 1998, J. Chem. Inf. Comput. Sci..

[22]  F. Dafae,et al.  Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting , 2012, BMC Microbiology.

[23]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .

[24]  Cees Neef,et al.  Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[25]  Tudor I. Oprea Chemoinformatics in Drug Discovery: OPREA:CHEMOINFORMATICS O-BK , 2005 .

[26]  Roberto Todeschini,et al.  Handbook of Molecular Descriptors , 2002 .

[27]  Francisco Torrens,et al.  Bond‐Based 2D Quadratic Fingerprints in QSAR Studies: Virtual and In vitro Tyrosinase Inhibitory Activity Elucidation , 2010, Chemical biology & drug design.

[28]  Harma A. Karsens,et al.  Large-Scale Screening of a Targeted Enterococcus faecalis Mutant Library Identifies Envelope Fitness Factors , 2011, PloS one.

[29]  Humberto González-Díaz,et al.  First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines , 2011, Molecular Diversity.

[30]  Maykel Cruz-Monteagudo,et al.  Chemometrics for QSAR with low sequence homology: Mycobacterial promoter sequences recognition with 2D-RNA entropies , 2007 .

[31]  Pawel Lewicki,et al.  Statistics : methods and applications : a comprehensive reference for science, industry, and data mining , 2006 .

[32]  Alejandro Speck-Planche,et al.  Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals. , 2013, Bioorganic & medicinal chemistry.

[33]  Yovani Marrero-Ponce,et al.  Non-stochastic and stochastic linear indices of the molecular pseudograph’s atom-adjacency matrix: a novel approach for computational in silico screening and “rational” selection of new lead antibacterial agents , 2006, Journal of molecular modeling.

[34]  Han van de Waterbeemd,et al.  Chemometric Methods in Molecular Design: van de Waterbeemd/Chemometric , 1995 .

[35]  M. C. Vega,et al.  Ligand-based discovery of novel trypanosomicidal drug-like compounds: in silico identification and experimental support. , 2011, European journal of medicinal chemistry.

[36]  W. L. Jorgensen The Many Roles of Computation in Drug Discovery , 2004, Science.

[37]  A. Magill,et al.  Application of 3D-QSAR for identification of descriptors defining bioactivity of antimicrobial peptides. , 2007, Journal of medicinal chemistry.

[38]  Max Dobler,et al.  5D-QSAR: the key for simulating induced fit? , 2002, Journal of medicinal chemistry.

[39]  Jann Hau,et al.  Handbook of Laboratory Animal Science, Second Edition: Essential Principles and Practices, Volume I , 2002 .

[40]  Maykel Pérez González,et al.  Designing Antibacterial Compounds through a Topological Substructural Approach , 2004, J. Chem. Inf. Model..

[41]  Nathan Brown,et al.  Exploiting QSAR methods in lead optimization. , 2006, Current opinion in drug discovery & development.

[42]  Gajendra P. S. Raghava,et al.  Analysis and prediction of antibacterial peptides , 2007, BMC Bioinformatics.

[43]  Ruth Brenk,et al.  Mining the ChEMBL Database: An Efficient Chemoinformatics Workflow for Assembling an Ion Channel-Focused Screening Library , 2011, J. Chem. Inf. Model..

[44]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[45]  J. Mcgowan,et al.  The Epidemiology of Bacterial Resistance to Antimicrobial Agents , 2009 .

[46]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[47]  H. Kubinyi QSAR : Hansch analysis and related approaches , 1993 .

[48]  Ernesto Estrada,et al.  Spectral Moments of the Edge Adjacency Matrix in Molecular Graphs, 1. Definition and Applications to the Prediction of Physical Properties of Alkanes , 1996, J. Chem. Inf. Comput. Sci..

[49]  Eugenio Uriarte,et al.  Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors. , 2009, Molecular pharmaceutics.

[50]  Ronald N. Jones,et al.  Antimicrobial Activity of the Investigational Pleuromutilin Compound BC-3781 Tested against Gram-Positive Organisms Commonly Associated with Acute Bacterial Skin and Skin Structure Infections , 2012, Antimicrobial Agents and Chemotherapy.

[51]  Han van de Waterbeemd,et al.  Chemometric methods in molecular design , 1995 .

[52]  CHUN WEI YAP,et al.  PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..

[53]  Otto X. Cordero,et al.  Ecological Populations of Bacteria Act as Socially Cohesive Units of Antibiotic Production and Resistance , 2012, Science.

[54]  Francisco Torrens,et al.  Relations frequency hypermatrices in mutual, conditional, and joint entropy‐based information indices , 2013, J. Comput. Chem..

[55]  G. Rossolini,et al.  Antimicrobial resistance in Europe and its potential impact on empirical therapy. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[56]  Roberto Todeschini,et al.  Molecular descriptors for chemoinformatics , 2009 .

[57]  P. Wipf,et al.  Combinatorial chemistry and contemporary pharmacology. , 2000, The Journal of pharmacology and experimental therapeutics.

[58]  E. Nudler,et al.  H2S: A Universal Defense Against Antibiotics in Bacteria , 2011, Science.

[59]  R. Uddin,et al.  Combined Pharmacophore and 3D‐QSAR Study on A Series of Staphylococcus aureus Sortase A inhibitors , 2012, Chemical biology & drug design.

[60]  Ramón García-Domenech,et al.  Antimicrobial Activity Characterization in a Heterogeneous Group of Compounds , 1998, J. Chem. Inf. Comput. Sci..

[61]  R. Todeschini,et al.  Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing / Volume II: Appendices, References , 2009 .

[62]  Tudor I. Oprea,et al.  Chemoinformatics in drug discovery , 2005 .

[63]  Humberto González-Díaz,et al.  ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen. , 2012, Bioorganic & medicinal chemistry.

[64]  E. Lautenbach,et al.  Healthcare-Acquired Bacterial Infections , 2009 .

[65]  Alejandro Speck-Planche,et al.  New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[66]  Enrique Molina Pérez,et al.  Can 3D Structural Parameters Be Predicted from 2D (Topological) Molecular Descriptors? , 2001, J. Chem. Inf. Comput. Sci..

[67]  H. Kubinyi QSAR: Hansch Analysis and Related Approaches: Kubinyi/QSAR , 1993 .

[68]  Kunal Roy,et al.  QSTR with Extended Topochemical Atom Indices. 2. Fish Toxicity of Substituted Benzenes , 2004, J. Chem. Inf. Model..

[69]  A. Vedani,et al.  Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor. , 2005, Journal of medicinal chemistry.

[70]  Tudor I. Oprea,et al.  Pursuing the leadlikeness concept in pharmaceutical research. , 2004, Current opinion in chemical biology.

[71]  A. J. Hopfinger,et al.  Pharmacological Activity and Membrane Interactions of Antiarrhythmics: 4D-QSAR/QSPR Analysis , 1998, Pharmaceutical Research.

[72]  Feng Luan,et al.  Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates. , 2013, ACS chemical neuroscience.

[73]  H. González-Díaz,et al.  A QSPR-like model for multilocus genotype networks of Fasciola hepatica in Northwest Spain. , 2014, Journal of theoretical biology.

[74]  Afshin Fassihi,et al.  Computer-aided design of novel antibacterial 3-hydroxypyridine-4-ones: application of QSAR methods based on the MOLMAP approach , 2012, Journal of Computer-Aided Molecular Design.

[75]  V. V. Kleandrova,et al.  Chemoinformatics in anti-cancer chemotherapy: multi-target QSAR model for the in silico discovery of anti-breast cancer agents. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[76]  R. Gonzales,et al.  A shrinking window of opportunity , 2008, BMJ : British Medical Journal.

[77]  D. Livermore Kucers' The use of antibiotics , 2011 .

[78]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[79]  Kenji Suzuki,et al.  Artificial Neural Networks - Methodological Advances and Biomedical Applications , 2011 .

[80]  Alejandro Speck-Planche,et al.  Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry. , 2013, Current topics in medicinal chemistry.

[81]  Alejandro Speck-Planche,et al.  Fragment-based approach for the in silico discovery of multi-target insecticides , 2012 .

[82]  J. Gálvez,et al.  Event-based criteria in GT-STAF information indices: theory, exploratory diversity analysis and QSPR applications , 2013, SAR and QSAR in environmental research.

[83]  Feng Luan,et al.  In silico discovery and virtual screening of multi-target inhibitors for proteins in Mycobacterium tuberculosis. , 2012, Combinatorial chemistry & high throughput screening.

[84]  Marina Lasagni,et al.  New molecular descriptors for 2D and 3D structures. Theory , 1994 .

[85]  Ernesto Estrada,et al.  Spectral Moments of the Edge-Adjacency Matrix of Molecular Graphs, 2. Molecules Containing Heteroatoms and QSAR Applications , 1997, J. Chem. Inf. Comput. Sci..